RBC Capital analyst Gregory Renza lowered the firm’s price target on Jasper Therapeutics (JSPR) to $48 from $68 and keeps an Outperform rating on the shares. The selloff in Jasper shares ...

BTIG analyst Justin Zelin lowered the firm’s price target on Jasper Therapeutics (JSPR) to $64 from $90 and keeps a Buy rating on the shares after the company presented data for briquilimab from ...

Hospitality commerce company GoTab has unveiled the new pricing rules engine functionality designed for menu management, improved price transparency and guest engagement. This tool provides ...

GoTab’s engine supports compliance by integrating charges into menu prices. Credit: shisu_ka/Shutterstock. Hospitality commerce company GoTab has unveiled the new pricing rules engine functionality ...

The pricing engine ingests and updates pricing for a lender’s investors and aggregators automatically. With granular controls for administrators, including global and product-level pricing ...